Skip to main content
logo
Novo Nordisk A/S (NVO)
NYSE: NVO · Real-Time Price · USD
50.32
+1.27 (2.58%)
Dec 11, 2025, 11:10 AM EST - Market open

Novo Nordisk Revenue by Segment

Period EndingJun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021Dec 31, 2020Sep 30, 2020Jun 30, 2020Mar 31, 2020Dec 31, 2019
Diabetes
33.24B33.02B32.22B30.89B30.06B28.45B27.05B25.13B
Diabetes Growth
10.57%16.05%19.11%22.93%24.59%23.92%24.31%21.21%
Obesity
12.32B11.31B10.16B8.57B7.55B6.99B6.49B5.60B
Obesity Growth
63.15%61.82%56.48%53.16%73.14%110.41%146.87%159.42%
Rare Disease
3.09B2.94B2.91B2.73B2.63B2.65B2.68B2.72B
Rare Disease Growth
17.73%11.21%8.60%0.34%-9.75%-14.09%-16.45%-14.49%

Operating Income by Segment

Period EndingJun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021Dec 31, 2020Sep 30, 2020Jun 30, 2020Mar 31, 2020Dec 31, 2019
Diabetes and Obesity Care
21.94B21.01B19.92B18.36B17.30B16.64B15.54B14.13B
Diabetes and Obesity Care Growth
26.80%26.31%28.20%29.95%35.29%41.90%47.82%45.45%
Rare Disease
328.11M83.59M96.69M103.08M78.60M426.52M460.20M361.64M
Rare Disease Growth
317.46%-80.40%-78.99%-71.50%-87.86%-50.18%-60.20%-74.47%

Revenue by Geography

Period EndingJun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021Dec 31, 2020Sep 30, 2020Jun 30, 2020Mar 31, 2020Dec 31, 2019Sep 30, 2019Jun 30, 2019Mar 31, 2019Dec 31, 2018
North America
28.89B28.57B27.79B25.80B24.62B22.86B21.31B18.82B
North America Growth
17.33%24.96%30.41%37.09%44.35%46.01%49.97%42.69%
International
19.76B18.70B17.50B16.40B15.61B15.23B14.91B14.63B
International Growth
26.54%22.84%17.36%12.08%8.89%11.10%11.40%13.54%
Source: Business metrics provided by Main Street Data and sourced from official company press releases and documents.